Bethenny Frankel Divorcing Jason Hoppy















01/05/2013 at 05:00 PM EST







Bethenny Frankel and Jason Hoppy


Albert Michael/Startraks


It's official – Bethenny Frankel and Jason Hoppy's marriage is over.

Having announced a separation over the holidays, the reality star began the divorce process by filing earlier this week in New York, TMZ reports.

"It brings me great sadness to say that Jason and I are separating," Frankel, 42, had said in a statement Dec. 23. "This was an extremely difficult decision that as a woman and a mother, I have to accept as the best choice for our family."

The split comes after months of rumors that the pair – who married in 2010 and are parents to daughter Bryn, 2½ – were on the rocks.

"Bethenny is devastated," a friend tells PEOPLE.

Read More..

FDA: New rules will make food safer


WASHINGTON (AP) — The Food and Drug Administration says its new guidelines would make the food Americans eat safer and help prevent the kinds of foodborne disease outbreaks that sicken or kill thousands of consumers each year.


The rules, the most sweeping food safety guidelines in decades, would require farmers to take new precautions against contamination, to include making sure workers' hands are washed, irrigation water is clean, and that animals stay out of fields. Food manufacturers will have to submit food safety plans to the government to show they are keeping their operations clean.


The long-overdue regulations could cost businesses close to half a billion dollars a year to implement, but are expected to reduce the estimated 3,000 deaths a year from foodborne illness. The new guidelines were announced Friday.


Just since last summer, outbreaks of listeria in cheese and salmonella in peanut butter, mangoes and cantaloupe have been linked to more than 400 illnesses and as many as seven deaths, according to the federal Centers for Disease Control and Prevention. The actual number of those sickened is likely much higher.


Many responsible food companies and farmers are already following the steps that the FDA would now require them to take. But officials say the requirements could have saved lives and prevented illnesses in several of the large-scale outbreaks that have hit the country in recent years.


In a 2011 outbreak of listeria in cantaloupe that claimed 33 lives, for example, FDA inspectors found pools of dirty water on the floor and old, dirty processing equipment at Jensen Farms in Colorado where the cantaloupes were grown. In a peanut butter outbreak this year linked to 42 salmonella illnesses, inspectors found samples of salmonella throughout Sunland Inc.'s peanut processing plant in New Mexico and multiple obvious safety problems, such as birds flying over uncovered trailers of peanuts and employees not washing their hands.


Under the new rules, companies would have to lay out plans for preventing those sorts of problems, monitor their own progress and explain to the FDA how they would correct them.


"The rules go very directly to preventing the types of outbreaks we have seen," said Michael Taylor, FDA's deputy commissioner for foods.


The FDA estimates the new rules could prevent almost 2 million illnesses annually, but it could be several years before the rules are actually preventing outbreaks. Taylor said it could take the agency another year to craft the rules after a four-month comment period, and farms would have at least two years to comply — meaning the farm rules are at least three years away from taking effect. Smaller farms would have even longer to comply.


The new rules, which come exactly two years to the day President Barack Obama's signed food safety legislation passed by Congress, were already delayed. The 2011 law required the agency to propose a first installment of the rules a year ago, but the Obama administration held them until after the election. Food safety advocates sued the administration to win their release.


The produce rule would mark the first time the FDA has had real authority to regulate food on farms. In an effort to stave off protests from farmers, the farm rules are tailored to apply only to certain fruits and vegetables that pose the greatest risk, like berries, melons, leafy greens and other foods that are usually eaten raw. A farm that produces green beans that will be canned and cooked, for example, would not be regulated.


Such flexibility, along with the growing realization that outbreaks are bad for business, has brought the produce industry and much of the rest of the food industry on board as Congress and FDA has worked to make food safer.


In a statement Friday, Pamela Bailey, president of the Grocery Manufacturers Association, which represents the country's biggest food companies, said the food safety law "can serve as a role model for what can be achieved when the private and public sectors work together to achieve a common goal."


The new rules could cost large farms $30,000 a year, according to the FDA. The agency did not break down the costs for individual processing plants, but said the rules could cost manufacturers up to $475 million annually.


FDA Commissioner Margaret Hamburg said the success of the rules will also depend on how much money Congress gives the chronically underfunded agency to put them in place. "Resources remain an ongoing concern," she said.


The farm and manufacturing rules are only one part of the food safety law. The bill also authorized more surprise inspections by the FDA and gave the agency additional powers to shut down food facilities. In addition, the law required stricter standards on imported foods. The agency said it will soon propose other overdue rules to ensure that importers verify overseas food is safe and to improve food safety audits overseas.


Food safety advocates frustrated over the last year as the rules stalled praised the proposed action.


"The new law should transform the FDA from an agency that tracks down outbreaks after the fact, to an agency focused on preventing food contamination in the first place," said Caroline Smith DeWaal of the Center for Science in the Public Interest.


Read More..

Diabetes is a stubborn adversary









One by one, the diabetic patients reluctantly stepped on the scale in the basement of a South Los Angeles clinic. Nearby, a nurse scribbled numbers on a chart.

Camara January, 31, her round face framed by a sparkly headband, held her breath. The number stopped at 245 pounds. "That's not good," January said. Tracy Donald, 45, stepped up. Just under 240 pounds. "That is wrong," she said. Ramon Marquez, 62, tall and clean-shaven, methodically took off his watch, his cap and his shoes. 170 pounds. Ramon strips down to almost nothing, the others jokingly complain.

They are among those who come each month to the To Help Everyone (T.H.E.) Clinic, hoping to finally gain the upper hand on their diabetes, a disease wreaking havoc on their bodies — and their community. Several have been hospitalized. Some have seen relatives die from complications. All have struggled to manage blood sugar levels that spike and plummet to ominous extremes.

FULL COVERAGE: T.H.E. Clinic in South L.A.

A chronic illness that can lead to heart attacks, blindness and kidney failure, diabetes is exploding across the United States and raising enormous obstacles to the Obama administration's drive to control costs and reform the healthcare system. In California alone, the disease costs taxpayers and businesses roughly $24 billion annually. One in seven California residents has diabetes — a 32% increase in the last decade.

"This is a train going in the wrong direction," said Dean Schillinger, a UC San Francisco Medical School professor and medical officer at the California Diabetes Program, run by the university and the state public health department.

Community health centers like T.H.E. Clinic are a crucial front line in the federal government's war against diabetes. They're charged with slowing the advance of the disease, which disproportionately affects poor patients whose care may be taxpayer-funded.

To do so, clinics must get millions of patients to change deeply ingrained eating habits, embrace regular exercise regimens and better manage their health to avoid unnecessary hospitalizations.

Many low-income, urban patients struggle with the willpower challenges afflicting diabetes sufferers everywhere. But their struggle is often complicated by limited understanding of the links between lifestyle and blood sugar levels, along with fewer safe, affordable and convenient options for healthy activities and fresh food.

"The approach of telling people they need to lose weight and exercise is clearly not working," said Martha Funnell, past chairwoman of the National Diabetes Education Program.

::

Like her mother and grandmother, 17-year-old Charnay Winbush has diabetes. She injects herself with insulin five times a day and wears a bracelet identifying her illness. But Charnay often tells people she isn't diabetic.

Without her injections, she feels weak and tired. When her blood sugar levels climb, she gets extremely thirsty and can't stop sweating. One incident sent her to the emergency room this summer. "I was scared," she said.

Doctors at T.H.E. Clinic tell Charnay she needs to lose weight, but she continues to gain. She keeps small bags of candy in the refrigerator next to her insulin. Counting calories brings unwelcome memories of math class, she says. The only exercise she likes is playing virtual tennis or bowling.

The diabetes battle permeates almost every aspect of T.H.E Clinic's routine. Patients are greeted in the waiting room by television programs about the disease. They are routinely tested for it, counseled about how to prevent it and referred to nutritionists and diabetic education groups to manage it.

Research shows such efforts can produce results. Patients surrounded by support and education programs do better at controlling their blood sugar, eat more healthfully and use their medication as recommended.

At the Saturday session, retired nurse Emily Moore handed out a soul food cookbook with healthy recipes. Patients shared about their favorite types of exercise. One woman said she liked dancing to disco music, another announced she was going to Zumba classes.

The sessions began as a diabetes education class but soon morphed into a less formal support group, said M.D. Donnell, education manager at T.H.E. Clinic. Patients say they come for the snacks, the nutrition advice and the camaraderie. James Hicks, whose leg was amputated after a diabetes-related infection, said he serves as a cautionary tale for others. "You never want to get this far," he said.

Despite the intense focus, a quarter of the clinic's diabetic patients haven't brought the disease under control, records show. Cynthia Francis, a physician assistant, dispenses sober warnings along with hope. "You have to be real with them," she said. "You have to tell them that managing their disease is a life-or-death situation."

Read More..

Plane Carrying Vittorio Missoni Lost Near Venezuela



MILAN — The Italian fashion designer Vittorio Missoni, the head of the prominent fashion house, was aboard a small plane that has disappeared off the coast of Venezuela, a company spokeswoman said on Saturday.


“The Missoni family has been informed by the Venezuelan Consulate that Vittorio Missoni and his wife are missing, but we don’t know any more,” the spokeswoman, Maddalena Aspes, said. “The authorities will resume their search for the plane in the morning.”


Italian media reported that the plane went missing on Friday morning after takeoff from the resort of Los Roques, an island off the coast of Venezuela. Also reported to have been aboard the plane with Mr. Missoni, 58, and his wife, Maurizia Castiglioni, were another couple and two Venezuelan crew members.


Mr. Missoni is the son of the founders of the family owned fashion house famous for its exuberantly colored knits, featuring bold stripes and zigzags. He owned the business with two siblings, Luca and Angela.


Read More..

Cricketer Herath alive and bowling despite death rumors






SYDNEY (Reuters) – As Mark Twain might have said, rumors of the death of Sri Lankan spinner Rangana Herath which spread like wildfire across social media late on Friday proved to be greatly exaggerated.


Far from lying in a Sydney morgue alongside former test bowler Chaminda Vaas after perishing in a car crash as the reports had suggested, Herath was very much alive when he pitched up for work at the Sydney Cricket Ground on Saturday.






The most prolific wicket-taker in test cricket last year, the 34-year-old leg spinner claimed two Australian wickets to seal a haul of four for 95 and then contributed nine runs with the bat.


Team mate Dimuth Karunaratne told reporters at the conclusion of the day’s play that the team had been dumbfounded by the rumors.


“I heard about it when we having breakfast but I had no idea where that came from,” he said with a laugh.


“Guys from Sri Lanka were calling us asking ‘when is the funeral?’ and stuff like that.


“Rangana is alive,” he added, somewhat unnecessarily.


Herath’s efforts were not enough to prevent Australia taking an iron grip on the third test match on Saturday and move to the brink of a 3-0 series sweep.


That could all change, however, if he and Dinesh Chandimal, who finished the third day unbeaten on 22, are able to dig in on Sunday, inflate their lead beyond the current 87 and give Sri Lanka a decent target to bowl at.


The Sydney track has traditionally offered a lot of turn for spinners in the last couple of days of a test and, as Herath’s 60 wickets last year showed, there are few better spinners operating in test cricket at the moment.


“The wicket is turning a lot now and the Aussie guys are playing the fourth innings, so I think Rangana… can do something,” said Karunaratne.


Vaas has no position with the test team and remains, also unharmed, in Sri Lanka, Sri Lankan reporters said.


(Editing by John O’Brien)


Internet News Headlines – Yahoo! News





Title Post: Cricketer Herath alive and bowling despite death rumors
Url Post: http://www.news.fluser.com/cricketer-herath-alive-and-bowling-despite-death-rumors/
Link To Post : Cricketer Herath alive and bowling despite death rumors
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

St. Barts! Cabo! See Where Stars Holiday in the Sun





From St. Barts to Cabo San Lucas, see how Julianne Hough, Jessica Alba, Sofia Vergara and more are heating things up this winter








Credit: FameFlynet



Updated: Friday Jan 04, 2013 | 06:00 AM EST
By: Kiran Hefa




Subscribe Now




Read More..

Seizures of Illegal Ivory Are Rising in Hong Kong


Kin Cheung/Associated Press


The smuggled ivory shipment confiscated by custom officials in Hong Kong was valued at around $1.4 million.







HONG KONG — Customs officials in Hong Kong announced on Friday their third large seizure of smuggled ivory in less than three months, saying they had intercepted 779 elephant tusks weighing 2,900 pounds in a container originating from Kenya.




The shipment was valued at around $1.4 million.


In October, 1,209 tusks weighing 3.8 tons and worth about $3.5 million were seized from two containers shipped from Tanzania and Kenya. The following month, 1.6 tons were discovered in a container originating from Tanzania.


Large seizures also have been made in other countries recently, notably in Port Klang, Malaysia, last month.


Demand from an increasingly affluent Asia and improved international trade and transport links have caused the trade in ivory and other wildlife products to soar in recent years, pushing many species to the brink. Meanwhile, in many countries enforcement and penalties remain weak and constitute little deterrent to smugglers and poachers, conservationists say.


A total of about 10 tons of ivory was seized by customs officials around the world in 2007, according to Traffic, an organization that monitors wildlife trade. By 2011, that figure had jumped to nearly 40 tons — a record. Much of that ivory came from large hauls — weighing 1,600 pounds or more — indicating the rising involvement of organized criminal gangs, Traffic said.


Official records for 2012 are not yet complete, but the quantity of raw ivory already reported seized in the past year totals nearly 27.5 tons, according to Traffic.


“2011 still reigns supreme as the ‘annus horribilis’, but last December’s Malaysia seizure pushes 2012 into the top four years of highest ivory seizures by weight, indicating the illegal ivory trade is still running rampant,” Tom Milliken, Traffic’s elephant expert, wrote in an e-mail.


No arrests have been made in connection with Friday’s seizure in Hong Kong. Customs officials said Friday that a fictitious address in Hong Kong had been listed at the shipment’s destination, and that their investigations were continuing.


There were no indications that Hong Kong was becoming a more important transshipment point for ivory smuggling, they said, adding that the three recent hauls were “isolated” events.


The smugglers, said Vincent Wong, a senior official in the Hong Kong customs department, were adopting new approaches all the time, diversifying routes and using different concealment measures.


Friday’s batch of ivory contained some whole tusks, but also many that had been cut into two or three pieces, allowing them to fit into five wooden crates transported among a shipment declared as containing “architectural stones.”


Read More..

Huawei launches the Ascend P1 in the U.S. for $450 through Amazon






Despite its attempts to attract new customers with high-end phones, Huawei (002502) remains relatively unknown to U.S. consumers. The company is looking to change that and on Thursday announced the availability of the Ascend P1 smartphone. The Android-powered device is equipped with a 4.3-inch Super AMOLED display, a 1.5GHz dual-core processor, 1GB of RAM and an 8-megapixel rear camera. The handset is also one of the thinnest smartphones on the market, measuring in at 7.6 millimeters. BGR reviewed the Ascend P1 earlier this year and found it to be a decent smartphone. Huawei is offering the device carrier-unlocked through Amazon (AMZN) for $ 449.99. Read more for Huawei’s press release.


[More from BGR: Samsung confirms plan to begin inching away from Android]







Huawei’s Ascend P1 Launches in U.S.


[More from BGR: ‘iPhone 5S’ to reportedly launch by June with multiple color options and two different display sizes]


Super thin Huawei Ascend P1 comes with 1.5 GHz dual-core processor and Android 4.0 ICS OS


PLANO, Texas, Jan. 3, 2013 /PRNewswire/ — Huawei, a leading global information and communications technology (ICT) solutions provider, today announced an unlocked version of the Huawei Ascend P1 is available to U.S. consumers through Amazon.com. The Huawei Ascend P1 comes equipped with 1.5 GHz dual-core processor and is one of the fastest models in class, capable of handling 3D games effectively.


“The Ascend P1 is perfect for consumers looking to get the most out of their device,” said Michael Chuang, Executive Vice President of Huawei Device USA. “Whether it’s for playing games, streaming music and videos, or sharing multimedia in the home or workplace, the Ascend P1 offers unparalleled performance and a truly unique mobile experience.”


The Ascend P1 offers users a movie theatre-quality cinematic experience with its super AMOLED, 4.3 inch screen and 5.1 Dolby Surround Sound System. In addition, at only 7.69 mm thick, the Huawei Ascend P1 is one of the thinnest smartphones on the market. The 64.8 mm frame allows the Ascend P1 to sit comfortably in the user’s palm, giving them the ability to navigate all the phone’s features with a single hand.


The Huawei Ascend P1 is available online at Amazon.com for $ 449.99.



This article was originally published by BGR


Wireless News Headlines – Yahoo! News





Title Post: Huawei launches the Ascend P1 in the U.S. for $450 through Amazon
Url Post: http://www.news.fluser.com/huawei-launches-the-ascend-p1-in-the-u-s-for-450-through-amazon/
Link To Post : Huawei launches the Ascend P1 in the U.S. for $450 through Amazon
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Kelly Clarkson: 'I've Never Been Truly Loved' Until Now















01/04/2013 at 09:45 AM EST



As she prepares to walk down the aisle, Kelly Clarkson has no doubts about her groom-to-be, Nashville-based talent manager Brandon Blackstock.

"Brandon's totally the one," Clarkson, 30, tells Cosmopolitan for its February issue. "I've never been so happy."

After dating for a year, Blackstock, whose father Narvel Blackstock is Clarkson's manager (and Reba McEntire's husband), popped the question in December on what she called the "happiest night of my life."

But romance was a long time coming for the pair.

Kelly Clarkson: 'I've Never Been Truly Loved' Until Now| Couples, Engagements, Kelly Clarkson, Individual Class

Julianne Hough covers the February issue of Cosmopolitan

Courtesy Cosmopolitan

"We've known each other for years, but we didn't start talking until the Super Bowl last February," Clarkson says in the issue, which hits newsstands Tuesday.

Though she's thrilled to be engaged, Clarkson wasn't sure when they first went out together. "This is the funniest/worst thing ever: One of my superhero idols is Whitney Houston, and the day she died was our first date," she says. "I was like 'This is a bad omen.' "

That turned out not to be true, but it seems that one thing is: love is worth waiting for: "Six years I was single before this," Clarkson says. "I've never been truly loved like I am right now."

Read More..

Indian court to rule on generic drug industry


NEW DELHI (AP) — From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.


The case — involving Swiss drug maker Novartis AG's cancer drug Glivec — pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. A ruling by India's Supreme Court is expected in early 2013.


"The implications of this case reach far beyond India, and far beyond this particular cancer drug," said Leena Menghaney, from the aid group Doctors Without Borders. "Across the world, there is a heavy dependence on India to supply affordable versions of expensive patented medicines."


With no costs for developing new drugs or conducting expensive trials, India's $26 billion generics industry is able to sell medicine for as little as one-tenth the price of the companies that developed them, making India the second-largest source of medicines distributed by UNICEF in its global programs.


Indian pharmaceutical companies such as Cipla, Cadila Laboratories and Lupin have emerged over the past decade as major sources of generic cancer, malaria, tuberculosis and AIDS drugs for poor countries that can't afford to pay Western prices.


The 6-year-old case that just wrapped up in the Supreme Court revolves around a legal provision in India's 2005 patent law that is aimed at preventing companies from getting fresh patents for making only minor changes to existing medicines — a practice known as "evergreening."


Novartis' argued that a new version of Glivec — marketed in the U.S. as Gleevec — was a significant change from the earlier version because it was more easily absorbed by the body.


India's Patent Controller turned down the application, saying the change was an obvious development, and the new medicine was not sufficiently distinct from the earlier version to warrant a patent extension.


Patient advocacy groups hailed the decision as a blow to "evergreening."


But Western companies argued that India's generic manufacturers were cutting the incentive for major drug makers to invest in research and innovation if they were not going to be able to reap the exclusive profits that patents bring.


"This case is about safeguarding incentives for better medicines so that patients' needs will be met in the future," says Eric Althoff, a Novartis spokesman.


International drug companies have accused India of disregarding intellectual property rights, and have pushed for stronger patent protection that would weaken India's generics industry.


Earlier this year, an Indian manufacturer was allowed to produce a far cheaper version of the kidney and liver cancer treatment sorefinib, manufactured by Bayer Corp.


Bayer was selling the drug for about $5,600 a month. Natco, the Indian company, said its generic version would cost $175 a month, less than 1/30th as much. Natco was ordered to pay 6 percent in royalties to Bayer.


Novartis says the outcome of the new case will not affect the availability of generic versions of Glivec because it is covered by a grandfather clause in India's patent law. Only the more easily absorbed drug would be affected, Althoff said, adding that its own generic business, Sandoz, produces cheap versions of its drugs for millions across the globe.


Public health activists say the question goes beyond Glivec to whether drug companies should get special protection for minor tweaks to medicines that others could easily have uncovered.


"We're looking to the Supreme Court to tell Novartis it won't open the floodgates and allow abusive patenting practices," said Eldred Tellis, of the Sankalp Rehabilitation Centre, a private group working with HIV patients.


The court's decision is expected to be a landmark that will influence future drug accessibility and price across the developing world.


"We're already paying very high prices for some of the new drugs that are patented in India," said Petros Isaakidis, an epidemiologist with Doctors Without Borders. "If Novartis' wins, even older medicines could be subject to patenting again, and it will become much more difficult for us in future to provide medicines to our patients being treated for HIV, hepatitis and drug resistant TB."


Read More..